ADMET Prediction Service - Neorabio
Neorabio provides ADMET prediction services to help research teams evaluate drug-like behavior before committing to costly experimental studies. Computational assessment of absorption, distribution, metabolism, excretion, and toxicity has become central to reducing project risk, a need underscored in early pharmacokinetic modeling work such as that discussed by van de Waterbeemd and Gifford (2003). Neorabio's workflows combine mechanistic modeling with machine-learning approaches, enabling early identification of liabilities and guiding molecular refinement with data-driven confidence.
